North America Ambulatory Infusion Pumps Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)

North America Ambulatory Infusion Pumps Market Trends and Drivers

Home Infusion Therapy Is Biggest Market Trend

• With the growing emphasis on cost-effectiveness in healthcare, there is a continuous shift of patients from expensive sites, including emergency and other hospital departments, to less-costly alternative sites, such as clinics/centers and homes.
• An average home infusion costs around USD 230, while hospital-based infusions cost USD 590 per patient per infusion.
• This equals an average saving of around USD 360 per patient per infusion.
• Additionally, such alternative sites and home-based care offer greater convenience. Hence, due to the rising availability of advanced ambulatory infusion pumps and cost-effectiveness of healthcare, is rapidly gaining acceptance among North American patients.

Growing Chronic Disease Burden Drives Product Demand

• The rising prevalence of chronic diseases is one of the major healthcare burdens in the U.S. and Canada.
• Some of the most-prevalent chronic diseases in the region are osteoarthritis, cancer, diabetes, fibromyalgia, sickle-cell anemia, and autoimmune diseases (such as rheumatoid arthritis), which require therapeutic intervention for proper pain management.
• Lung and bronchus cancer is responsible for the most deaths, with 130,180 people expected to die of it.
• That is nearly three times the 52,580 deaths due to colorectal cancer, which is the second-most-common cause of cancer deaths in the country.
• Moreover, among all types of chronic pain, lower back pain, neck pain, migraines, and facial pain constitute a major share in the U.S.
• Owing to the increasing prevalence of chronic diseases, several treatment options, such as medication, physiotherapy, psychological therapy, corrective surgery, therapeutic nerve blockers, and neuroablation, are used widely.
• Thus, the increasing use of chronic pain treatment drugs and infusion devices is an important factor driving the regional market.

High Cost of Infusion Pumps Poses Challenges for Players

• Chronic disease patients, such as those with acute respiratory distress syndrome, require prolonged hospital stays with frequent mechanical ventilation and medication administration.
• As a result, they consume a significant amount of healthcare resources, and the majority of them are discharged early in the course of treatment, because they cannot afford a lengthy stay.
• However, this raises the potential for and susceptibility to fresh infections and complications, thus necessitating more healthcare resources and care.
• Moreover, the usage of numerous treatment procedures and high-tech equipment for them is to blame for the high cost of hospital-based treatment.
• The high cost associated with using infusion pump systems is predicted to restrain the market for ambulatory infusion pumps because it raises the price of the treatment proportionally, as the cost of advanced infusion pumps is higher than of the standard ones.
• According to the Academy of Managed Care Pharmacy, insulin pumps cost between USD 4,500 and USD 6,500 for individuals without insurance, while an insulin pen without insurance starts at around USD 150.

North America Ambulatory Infusion Pumps Market Analysis

Product Type Analysis

Accessories & consumables hold the larger share of around 60%, and this category will also witness the higher CAGR during the forecast period. This is primarily due to their repetitive purchases and availability of a broad range of accessories & consumables across the region. Further, the growing trend of single-use and disposable consumables, especially since the pandemic, continues to drive this category.

The product types analyzed in the report are listed below:

• Devices
• Accessories & Consumables (Larger and Faster-Growing Category)

Route of Administration Analysis

The intravenous category is the largest, with around 75% market share in 2024, and it will also be the fastest growing during the forecast period. IV infusion pumps are used to administer medications and fluids directly into the veins of patients, which enables rapid effect. These devices also allow for better dosage and rate of infusion control and offer compatibility with a wider range of medicines. They are used in people of all ages who are sick, injured, dehydrated from exercise or heat, or undergoing surgery.

We have studied these routes of administration:

• Intravenous (Largest and Fastest-Growing Category)
• Subcutaneous
• Epidural

Application Analysis

Diabetes accounts for the largest revenue share, of 25%, in the North American ambulatory infusion pumps market in 2024. This can be attributed to the growing prevalence of diabetes and its complications in the region. Over 96 million people aged 18 years or older have prediabetes, which is 38.0% of the adult U.S. population. As it delivers doses of insulin at specific times, an infusion pump replaces the need for multiple daily injections with a continuous insulin infusion. Furthermore, the innovations in wearable diabetes management devices and their extended infusion periods are responsible for their rising adoption.

Oncology is the fastest-growing category in the market, primarily due to the rising incidence of cancer in the continent. As per the American Cancer Society, for the first time in recorded history, over 2 million new cancer diagnoses and 611,000 resulting deaths are expected in the U.S. in 2024. Infusion pumps are used for the delivery of chemotherapy agents, a number of which must be delivered at a constant rate and controlled amount. Cancer also causes significant pain, which is why infusion pumps are deployed for patient-controlled analgesia in hospital, long-term care, and homecare settings.

The report offers insights in the following applications:

• Pain Management
• Diabetes (Largest Category)
• Oncology (Fastest-Growing Category)
• Neonatology
• Gastroenterology
• General Anesthesia
• Emergency Medicine
• Others

Distribution Channel Analysis

The direct category dominates the market, and it will also witness the higher CAGR, of around 75%, during this decade. This can be mainly due to the fact that this channel is preferred by individual consumers, who are increasingly buying infusion pumps for home-based care. Moreover, the increasing utilization of e-prescriptions in the hospitals in the region is expected to support the market growth in this category during the forecast period. Moreover, the majority of the healthcare service providers in the continent, including hospitals, clinics, long-term-care centers, and hospice care centers, buy directly from the manufacturers, often in bulk, under long-term supply agreements.

These distribution channels are part of the research scope:

• Direct (Larger and Faster-Growing Category)
• Indirect

Regional Analysis

The U.S. holds the larger share, of around 90%, in 2024, because of the presence of major players, developed healthcare infrastructure, favorable reimbursement policies, and surging prevalence of chronic diseases. In addition to this, the development of alternative healthcare settings and penetration of different home infusion services are contributing to the growth of the market. Furthermore, the presence of a large number of hospitals in the U.S. is expected to continue driving the regional market growth. According to the American Hospital Association (AHA), a total of 6,093 hospitals were operational in the U.S. in 2021, and, in 2024, the number has risen to 6,120. Moreover, the U.S. is home to 334.9 million people, while Canada is home to merely 40.1 million. This large difference means that the U.S. will continue to have the larger geriatric population and pool of patients with numerous acute and chronic diseases throughout this decade and beyond.

Here are the countries covered in the report:

• U.S. (Larger and Faster-Growing Country Market)
• Canada

North America Ambulatory Infusion Pumps Market Share

The market is fragmented as there are both large multinational corporations and small, niche companies serving patient needs. While some companies offer comprehensive portfolios, the specialized ones generally focus on specific applications, such as chemotherapy or pain management. The pumps might even need to be customized as per the application, furthering the scope for new companies and intensifying the competition. Moreover, the increasing ‘connectedness’ of the healthcare system is impelling players to bring innovative features in their offerings, such as remote patient data sharing and EHR integration. The players also use diverse distribution channels; while to hospitals, they generally sell directly, to individuals, they market through specialty medical device stores and even online.

North America Ambulatory Infusion Pumps Market News

• In November 2024, ICU Medical Inc. formed a joint venture with Otsuka Holdings Co. Ltd. subsidiary Otsuka Pharmaceutical Factory Inc. for producing IV pumps and consumables in North America.
• In October 2024, KORU Medical Systems participated in the Partnership Opportunities in Drug Delivery (PODD) Conference, where it presented data in support of the usage of its KORU FreedomEdge Infusion System over manual subcutaneous injections for cancer therapy.
• In May 2024, Moog Inc. announced the FDA 510(k) approval for its CURLIN 8000 ambulatory infusion system. Designed for home use, the system is compatible with the URLIN RxManager medication safety software.
• In December 2023, Fresenius Kabi, a prominent subsidiary of Fresenius SE & Co. KGaA, signed a multi-year agreement to supply 10,000 units of its Ivenix large-volume infusion pumps to the hospitals and clinics operated by Mayo Clinica in Arizona, Minnesota, and Florida.